Patient Information Leaflets (PILs)
These Patient Information Leaflets (PILs) are specially written by the British Association of Dermatologists (BAD).
The BAD has been awarded The Information Standard certification for the process it employs to develop information products aimed at the general public, which include PILs, Sun Awareness Campaign materials, and other information products.
The BAD shall hold responsibility for the accuracy of the information published, and neither the scheme operator nor the scheme owner shall have any responsibility for costs, losses, or direct or indirect damages or costs arising from inaccuracy of information or omissions in information published on the website on behalf of the BAD.
Methotrexate is known as a disease-modifying drug or DMARD. It slows the production of new cells by the body’s immune system (the body's immune defence system) and reduces inflammation. It was first used to treat certain types of cancer and was discovered to be an effective treatment for skin and joint diseases when used at lower doses.